Cargando…
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
[Image: see text] Protein lysine methyltransferases have recently emerged as a new target class for the development of inhibitors that modulate gene transcription or signaling pathways. SET and MYND domain containing protein 2 (SMYD2) is a catalytic SET domain containing methyltransferase reported t...
Autores principales: | Eggert, Erik, Hillig, Roman C., Koehr, Silke, Stöckigt, Detlef, Weiske, Jörg, Barak, Naomi, Mowat, Jeffrey, Brumby, Thomas, Christ, Clara D., ter Laak, Antonius, Lang, Tina, Fernandez-Montalvan, Amaury E., Badock, Volker, Weinmann, Hilmar, Hartung, Ingo V., Barsyte-Lovejoy, Dalia, Szewczyk, Magdalena, Kennedy, Steven, Li, Fengling, Vedadi, Masoud, Brown, Peter J., Santhakumar, Vijayaratnam, Arrowsmith, Cheryl H., Stellfeld, Timo, Stresemann, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917279/ https://www.ncbi.nlm.nih.gov/pubmed/27075367 http://dx.doi.org/10.1021/acs.jmedchem.5b01890 |
Ejemplares similares
-
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
por: Reynoird, Nicolas, et al.
Publicado: (2016) -
Discovery and
Characterization of BAY-805, a Potent
and Selective Inhibitor of Ubiquitin-Specific Protease USP21
por: Göricke, Fabian, et al.
Publicado: (2023) -
Targeting human SET1/MLL family of proteins
por: Vedadi, Masoud, et al.
Publicado: (2017) -
Discovery of Nedd4 auto-ubiquitination inhibitors
por: Yong, Darren, et al.
Publicado: (2023) -
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
por: Nguyen, Hannah, et al.
Publicado: (2015)